Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toxicities following CAR-T therapy for hematological malignancies
Rafael Hernani, Ana Benzaquén, Carlos Solano
Cancer Treatment Reviews (2022) Vol. 111, pp. 102479-102479
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application
Qian Yang, Shisheng Li, Haibo Ou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 42
CAR‐T cell therapy in hematological malignancies: Where are we now and where are we heading for?
Aalia Khan, Sweety Asija, Juber Pendhari, et al.
European Journal Of Haematology (2023) Vol. 112, Iss. 1, pp. 6-18
Open Access | Times Cited: 29
EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome
Rafael Hernani, Mika Aiko, Ruth Victorio, et al.
Clinical Neurophysiology (2024) Vol. 163, pp. 132-142
Open Access | Times Cited: 9
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells
Yang Liu, Xingxing Jie, Nian Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Torque Teno Virus DNA Load in Blood as an Immune Status Biomarker in Adult Hematological Patients: The State of the Art and Future Prospects
Eliseo Albert, Estela Giménez, Rafael Hernani, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 459-459
Open Access | Times Cited: 6
Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease
Rong Jiang, Lian Lou, Wen Shi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10177-10177
Open Access | Times Cited: 5
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy
Lauren C. Peres, Laura B. Oswald, Christen Dillard, et al.
Blood Advances (2023) Vol. 8, Iss. 1, pp. 251-259
Open Access | Times Cited: 12
Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma
Lina Camacho-Arteaga, Gloria Iacoboni, Mi Kwon, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2461683-e2461683
Open Access
CART Cell Toxicities and Management
Nishanth Thalambedu, Sruthi Vellanki, Anup Kumar Trikannad, et al.
Biochemistry (2025)
Closed Access
In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines
Sikun Meng, Tomoaki Hara, Yutaka Miura, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3119-3119
Open Access
Depletion of CD8+ CAR T-cells leads to superior anti-tumor efficacy of pure CD4+ CAR T-cells against Acute Leukemias
Tim Sauer, Qian Chen, Hao Yao, et al.
Research Square (Research Square) (2025)
Closed Access
Cytokine release syndrome and neurotoxicity following CD19 CAR-T in B-cell lymphoma
Roni Shouval, Christopher Strouse, Soyoung Kim, et al.
Transplantation and Cellular Therapy (2025)
Closed Access
Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress
Adel Chergui, John L. Reagan
Cancers (2023) Vol. 15, Iss. 16, pp. 4137-4137
Open Access | Times Cited: 7
Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy
Baitao Dou, Shihui Ren, Ling Qiu, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 2
Chimeric antigen receptors: “CARs” in the fast lane for rheumatology
Nathan M. Johnson, Fotios Koumpouras
Current Opinion in Rheumatology (2024) Vol. 36, Iss. 3, pp. 176-183
Open Access | Times Cited: 2
Advancement and Challenges in Monitoring of CAR-T Cell Therapy: A Comprehensive Review of Parameters and Markers in Hematological Malignancies
Weronika Ploch, Karol Sadowski, Wioletta Olejarz, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3339-3339
Open Access | Times Cited: 2
Long-Term Safety and Efficacy of the Fully Human CAR-T Therapy CT103A in Relapsed/Refractory Multiple Myeloma
Qiuxia Yu, D. Wang, Zhe Li, et al.
Molecular Therapy (2024)
Closed Access | Times Cited: 2
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy
Ana Benzaquén, Estela Giménez, Gloria Iacoboni, et al.
Bone Marrow Transplantation (2023) Vol. 59, Iss. 1, pp. 93-100
Open Access | Times Cited: 6
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies
Yangjie Liu, Peng Cao, Faiza Ahad, et al.
Recent Patents on Anti-Cancer Drug Discovery (2024) Vol. 19, Iss. 5, pp. 557-572
Closed Access | Times Cited: 1
A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens
Zhenyu Xiong, Yaojia Shen, Shizhong Zhang, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Cytokine release syndrome after chimeric antigen receptor T cell therapy in patients with diffuse large B-cell lymphoma: a systematic review
A Santos, Daniela Zanini, Daniel Andolfatto
Hematology Transfusion and Cell Therapy (2024)
Open Access | Times Cited: 1
Promoting patient-centered care in CAR-T therapy for hematologic malignancy: a qualitative meta-synthesis
Caiqin Xie, Haoran Duan, Hui Liu, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 9
Open Access | Times Cited: 1
A Multifunctional Graphene Oxide-Based Nanodrug Delivery System for Tumor Targeted Diagnosis and Treatment under Chemotherapy-photothermal-photodynamic Synergy
Huirui Zhu, Rongjie Feng, Dawei Li, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 248, pp. 114479-114479
Closed Access | Times Cited: 1
Inflammatory abrasion of hematopoietic stem cells: a candidate clue for the post-CAR-T hematotoxicity?
Ting Sun, Dengju Li, Liang Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Potentially fatal complications of new systemic anticancer therapies: pearls and pitfalls in their initial management
Milena Kovač, Boštjan Šeruga
Radiology and Oncology (2024) Vol. 58, Iss. 2, pp. 170-178
Open Access
Page 1 - Next Page

Scroll to top